Home
Affinity Asset Advisors reported a 7.75% stake in Lexeo Therapeutics LXEO · 4,252,005 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 7.75%
- Last report
- First report
- Shares held
- 4,252,005 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- Affinity Asset Advisors
- Event date
- 25/05/28
- Filed
- 25/06/04
First 5%+ report · 7.75% stake
Lexeo Therapeutics trades, last 26 weeks
What else happened in Lexeo Therapeutics around then
Filed or reported within 30 days of the trade day · 25/04/28~25/06/27Affinity Asset Advisors's other 5% stake reports
- Affinity Asset Advisors
5% stakeLexeo Therapeutics
5% stakeLexeo Therapeutics
LXEO
8.4% stake
6,674,913 sh
8.4% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeEquillium
5% stakeEquillium
EQ
6.5% stake
4,100,000 sh
6.5% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeAmanat Acquisition
5% stakeAmanat Acquisition
AMAN
5% stake
375,000 sh
5% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeFirst Tracks Biotherapeutics
5% stakeFirst Tracks Biotherapeutics
TRAX
5.8% stake
2,032,012 sh
5.8% stake
Filed 08/13
- Affinity Asset Advisors
5% stakeOvid Therapeutics
5% stakeOvid Therapeutics
OVID
7.9% stake
15,143,728 sh
7.9% stake
Filed 08/13
